Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do These Ratios Tell Us About Unilever plc (ADR) (UL)?

LONDON — Before I decide whether to buy a company’s shares, I always like to look at two core financial ratios — return on equity and net gearing.

These two ratios provide an indication of how successful a company is at generating profits using shareholders’ funds and debt, and they have a strong influence on dividend payments and share price growth.

Unilever plc (ADR)Today, I’m going to take a look at consumer goods giant and Fool favorite Unilever plc (ADR) (NYSE:UL) to see how attractive it looks on these two measures.

Return on equity

The return a company generates on its shareholders’ funds is known as return on equity, or ROE. ROE can be calculated by dividing a company’s annual earnings by its equity (i.e., the difference between its total assets and its total liabilities) and is expressed as a percentage.

Let’s start with a look at Unilever plc (ADR) (NYSE:UL)’s ROE over the last five years:

Unilever 2008 2009 2010 2011 2012 Average
ROE 45% 30.6% 32% 29.6% 30.4% 33.5%

Unilever plc (ADR) (NYSE:UL)’s five-year average ROE of 33.5% is impressive, but to see how competitive it really is, we need to compare it to some of its peers, which I’ll do in a moment.

What about debt?

One weakness of ROE is that it doesn’t show how much debt a company is using to boost its returns. A good way of assessing a company’s debt levels is by looking at its net gearing — the ratio of net debt to equity.

In the table below, I’ve listed Unilever plc (ADR) (NYSE:UL)’s net gearing and ROE alongside those of its main U.K. rival, Reckitt Benckiser:

Company Net Gearing 5-Year
Average ROE
Unilever 48.5% 33.5%
Reckitt Benckiser 40.2% 35.3%

Unilever plc (ADR) (NYSE:UL)’s products are mostly staple goods that we will always buy, regardless of economic conditions. This provides Unilever with pricing power, which is also helped by customers’ loyalty to the firm’s brands.

I think that Reckitt’s growth may be harder to sustain, as it is dependent on high margins and a move into health care, which could expose it to tough new competition.

Unilever’s focus on food and personal hygiene products, and its strong emerging market growth, look much more attractive to me.

Is Unilever a buy?

Trading on a P/E of 20, Unilever’s shares are not cheap at the moment, but they do provide access to a high-quality income stream.

This year’s rising market has pushed Unilever’s dividend yield down to the FTSE 100 average, and at the firm’s current share price, I’d hold. However, if the market’s recent losses continue, and Unilever’s shares drop below 2,500 pence, I’d rate them a buy.

The article What Do These Ratios Tell Us About Unilever? originally appeared on and is written by Roland Head.

Roland Head owns shares of Unilever. The Motley Fool recommends Reckitt Benckiser Group and Unilever.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.